Evaluación de los riesgos del proceso de gestión de medicamentos y productos médicos

Frutos, Lorena Mariel; Melo Acevedo, María José; Lemonnier, Gabriela.
Rev. Hosp. El Cruce; (21): 10-15, 20181228. tab, graf
Artigo em Espanhol | LILACS | ID: biblio-915384

Documentos relacionados

  1. Utilizing the Failure Mode and Effects Analysis Tool to Assess and Address Risks Associated with Transitions in Care.
  2. Failure Mode and Effects Analysis (FMEA) for Immunogenicity of Therapeutic Proteins.
  3. [Risk Analysis of Radiotherapy Implementation Process Based on Failure Mode and Effect Analysis].
  4. The Healthcare Failure Mode and Effect Analysis as a tool to evaluate care protocols.
  5. Failure Mode and Effects Analysis (FMEA) at the preanalytical phase for POCT blood gas analysis: proposal for a shared proactive risk analysis model.
  6. Risk assessment of failure during transitioning from in-centre to home haemodialysis.
  7. Application of failure mode and effects analysis (FMEA) to improve medication safety in the dispensing process - a study at a teaching hospital, Sri Lanka.
  8. Improving the quality of hospital sterilization process using failure modes and effects analysis, fuzzy logic, and machine learning: experience in tertiary dental centre.
  9. Healthcare failure mode and effect analysis in the chemotherapy preparation process.
  10. Validation plan of bone marrow collection, processing and distribution using the failure mode and effect analysis methodology: a technical report.